PATENT CLAIM ANALYSIS

Application Number: 15771704
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["424", "472000"]

Abstract:
This invention relates to pharmaceutical controlled release compositions of salicylate-releasing actives for the treatment of tau protein-related neurodegenerative diseases and disorders.

Claim (Index 14):
The oral pharmaceutical composition of  claim 11 , wherein the pharmaceutically acceptable enteric polymer of one delayed release component substantially dissolves at about pH 6, and the pharmaceutically acceptable enteric polymer of the other delayed release component substantially dissolves at about pH 7.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15543199', '15010212', '10015930', '13186006', '11120139']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7573829752329742
- 35 USC 102 Novelty (BERT): 0.4979859128539248
- Combined Prediction Score: 0.7314432689950692
- Mean Citation Score: 237.953648
- Max Citation Score: 264.3504
- Similarity Product: 212.061643893528

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test